imaware Appoints Sol Rashidi to Advisory Board

(US and Canada) imaware, a health-tech company that specializes in at-home testing solutions, has recently appointed Sol Rashidi to its Advisory Board. Rashidi has worked across several verticals and sectors, she was the former CAO for Estee Lauder, Global CDAO for Merck, EVP and CDO for Sony Music, CDAIO for Royal Caribbean, Partner at E&Y, Chief Information and Digital Officer for Soli, and a key player in launching IBM's Gen-1 Watson. 

With eight patents granted, and as the first Chief Data and AI Officer appointed in 2016, Rashidi has received awards that include “Top 100 People in AI,” "Top 75 Innovators of 2023," “Forbes AI Maverick & Visionary of the 21st Century,” “50 Most Powerful Women in Tech,” “Global 100 Data Power List,” “Top 5 CDOs,” “Top 100 Innovators in Data & Analytics,” and more. She also holds a position on the CDO Magazine Global Editorial Board, showcasing her contributions to the field of data.

“Sol is uniquely positioned to advance imaware's data, AI, and technology capabilities to better empower the health of humanity. Her extensive background will help us set a high bar for the future of healthcare at home,” the imaware team shared in an official LinkedIn post.

“My passion for AI and background as a Chief Analytics and Data Officer at large Fortune 500 companies fits perfectly with imaware’s vision to enable everyone to manage their health and wellness from home,” shared Rashidi.